Reuters logo
a month ago
BRIEF-Neovacs announces license agreement for Ifnalpha Kinoid for treatment of lupus in Turkey
July 5, 2017 / 5:10 AM / a month ago

BRIEF-Neovacs announces license agreement for Ifnalpha Kinoid for treatment of lupus in Turkey

July 5 (Reuters) - NEOVACS SA

* REG-NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNALPHA KINOID FOR TREATMENT OF LUPUS IN TURKEY

* REG-NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNALPHA KINOID FOR TREATMENT OF LUPUS IN TURKEY

* UNDER TERMS OF AGREEMENT, NEOVACS WILL RECEIVE A TOTAL OF EUR 6 MILLION

* WILL RECEIVE DOUBLE DIGIT ROYALTIES ON NET SALES OF IFNALPHA KINOID IN TURKEY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below